RxDoctor Payments Data

Colby Mussett, DPM

Foot & Ankle Surgery · Gainesville, VANPI 1316476161

Payments from drug & device makers

$2,818in general payments, 2019–2025

Across 21 payments — averaging $134.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fortis Surgical, LLC$1K
  • Active Medical, LLC$950
  • Arthrex$288
  • Angiodynamics, Inc.$224
  • Medtronic$80
  • Smith+Nephew$45
  • plus $131 from 5 others

What the payments were for

  • Travel & lodging$1,17342%
  • Food & beverage$69525%
  • Education$95034%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Fortis Surgical, LLC5$1,101
Active Medical, LLC2$950
Arthrex3$288
Angiodynamics, Inc.2$224
Medtronic1$80
Smith+Nephew2$45
Organogenesis Inc.1$45
Innovation Technologies Inc1$30
Zyla Life Sciences, Inc.2$30
Integra Lifesciences Corporation1$15
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,818 in reported general payments places this provider in the 40th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$59,545
Medicare patients
186
Services billed
848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam16$31

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Gainesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →